Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002449821 | SCV002682724 | pathogenic | Hereditary cancer-predisposing syndrome | 2019-06-25 | criteria provided, single submitter | clinical testing | The c.1269delA pathogenic mutation, located in coding exon 7 of the MSH2 gene, results from a deletion of one nucleotide at nucleotide position 1269, causing a translational frameshift with a predicted alternate stop codon (p.K423Nfs*15). This variant has been reported in one Danish Lynch syndrome family (Nilbert M et al. Fam. Cancer, 2009 Jun;8:75-83). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |